Wells Fargo’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,296
Closed -$627 7368
2023
Q2
$627 Hold
3,296
﹤0.01% 6130
2023
Q1
$1.12K Buy
3,296
+200
+6% +$68 ﹤0.01% 6024
2022
Q4
$1K Sell
3,096
-11,397
-79% -$3.69K ﹤0.01% 5859
2022
Q3
$6K Buy
+14,493
New +$6K ﹤0.01% 5548
2022
Q1
Sell
-7,478
Closed -$10K 7521
2021
Q4
$10K Hold
7,478
﹤0.01% 6019
2021
Q3
$15K Hold
7,478
﹤0.01% 5755
2021
Q2
$12K Sell
7,478
-220,111
-97% -$353K ﹤0.01% 5761
2021
Q1
$506K Buy
227,589
+191,669
+534% +$426K ﹤0.01% 4382
2020
Q4
$90K Buy
35,920
+11,175
+45% +$28K ﹤0.01% 5232
2020
Q3
$61K Buy
24,745
+3,177
+15% +$7.83K ﹤0.01% 5215
2020
Q2
$76K Buy
+21,568
New +$76K ﹤0.01% 5121
2019
Q3
Sell
-2,279
Closed -$4K 6297
2019
Q2
$4K Sell
2,279
-12,164
-84% -$21.4K ﹤0.01% 5659
2019
Q1
$28K Sell
14,443
-4
-0% -$8 ﹤0.01% 5346
2018
Q4
$19K Sell
14,447
-2,567
-15% -$3.38K ﹤0.01% 5443
2018
Q3
$42K Sell
17,014
-8,169
-32% -$20.2K ﹤0.01% 5339
2018
Q2
$84K Buy
25,183
+10,687
+74% +$35.6K ﹤0.01% 5205
2018
Q1
$61K Buy
14,496
+5,193
+56% +$21.9K ﹤0.01% 5223
2017
Q4
$30K Buy
9,303
+6,124
+193% +$19.7K ﹤0.01% 5367
2017
Q3
$12K Buy
3,179
+2,129
+203% +$8.04K ﹤0.01% 5490
2017
Q2
$4K Hold
1,050
﹤0.01% 5597
2017
Q1
$3K Hold
1,050
﹤0.01% 5684
2016
Q4
$3K Hold
1,050
﹤0.01% 5668
2016
Q3
$3K Sell
1,050
-3,000
-74% -$8.57K ﹤0.01% 5662
2016
Q2
$13K Hold
4,050
﹤0.01% 5334
2016
Q1
$10K Hold
4,050
﹤0.01% 5455
2015
Q4
$13K Hold
4,050
﹤0.01% 5414
2015
Q3
$14K Hold
4,050
﹤0.01% 5379
2015
Q2
$5K Hold
4,050
﹤0.01% 5759
2015
Q1
$3K Hold
4,050
﹤0.01% 5690
2014
Q4
$2K Sell
4,050
-20,180
-83% -$9.97K ﹤0.01% 5771
2014
Q3
$105K Sell
24,230
-3,000
-11% -$13K ﹤0.01% 4540
2014
Q2
$135K Buy
27,230
+3,230
+13% +$16K ﹤0.01% 4454
2014
Q1
$131K Buy
24,000
+23,000
+2,300% +$126K ﹤0.01% 4450
2013
Q4
$6K Hold
1,000
﹤0.01% 5176
2013
Q3
$7K Hold
1,000
﹤0.01% 5094
2013
Q2
$5K Buy
+1,000
New +$5K ﹤0.01% 5099